Application to the skin or mucous membrane, with the active ingredient acting locally or absorbing into nearby tissue.
Cosmetic peptides (GHK-Cu, Matrixyl 3000, SNAP-8) are delivered topically. Therapeutic claims are restricted by EU CosIng to local barrier-function effects; any systemic claim moves a product from cosmetic to medicinal.